Pharmacokinetics, Tolerability, Immunogenicity, Dose Increasing Safety and Evaluate of Preliminary Effect Clinical Trial for High dose of GR1501 injection (200mg, 300mg) in Patients With Plaque Psoriasis
Latest Information Update: 01 Oct 2019
At a glance
- Drugs Xeligekimab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
Most Recent Events
- 01 Oct 2019 New trial record